Global C-Reactive Protein Testing Market by Assay Types (Immunoturbidimetric, ELISA, Turbidometric, and Others), Applications (Cardiovascular disease, Cancer, Diabetes, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others), End-uses (Clinics, Hospitals, Diagnostic Labs, and Others), and Regions (North America, Asia-Pacific, Latin America, Middle East and Africa, and Europe) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global C-reactive protein testing market was valued at USD 1.8 million in 2019 and is expected to reach USD 1.93 billion by 2028, expanding at a CAGR of 1.8% during the forecast period, 2021 – 2028. The growth of the market is attributed to increasing number of diseases such as rheumatoid arthritis, inflammatory bowel disease, cancer, and cardiovascular diseases.
C-reactive protein (CRP) is a substance produced by the liver, due to inflammation. C-reactive protein is known as High-Sensitivity C-reactive protein (HS-CRP) and Ultra-Sensitive C-reactive protein (US-CRP). A high level of CRP in blood causes inflammation in the body, which results in small infections to severe diseases.
C-reactive protein is measured in milligram of CRP per liter of blood (mg/L).
|
Reading |
Risk |
|
Less than 1 mg/L |
Low risk of cardiovascular disease |
|
Between 1 and 2.9 mg/L |
Intermediate risk |
|
Between 3 and 9.9 mg/L |
High risk |
High reading of above 10 mg/L indicates severe diseases including:
- Bone infection
- IBD
- Cancer
- Lupus, connective tissue disease, or other autoimmune diseases
- Tuberculosis
- Pneumonia
- Autoimmune arthritis flare-up
- Other diseases
Market Trends, Drivers, Restraints, Opportunity
- Increasing number of diseases such as rheumatoid arthritis, inflammatory bowel disease, cancers, and cardiovascular diseases, is a major driving force for the market.
- Technological advancement in diagnostics and increasing investments for diagnostics research are expected to drive the market during the forecast period.
- Increasing initiatives by international bodies for the prevention and treatment of chronic disorders is significantly accelerating the growth of the C-reactive protein testing market during the forecast period.
- Presence of bacterial and viral infection is diagnosed by C-reactive protein testing, which helps drive the market.
- Lack of public awareness regarding CRP (C-reactive protein) testing restrains the market growth.
- Other blood tests such as erythrocyte sedimentation rate (ESR) give accurate results when compared with the C-reactive protein testing market, which restrains the market growth.
Scope of the Report
The report on the global C-reactive protein testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Overall Period |
2018–2028 |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast |
Global C-reactive Protein Testing Market Segment Insights
Based on assay types, the market is divided into immunoturbidimetric, ELISA, Turbidometric, and others. The immunoturbidimetric assay segment has a considerable market share and this trend is expected to continue during the forecast period. Availability of highly sensitive automated immunoturbidimetric assays and increased exploratory activities in immunoturbidimetric assays are expected to play an important role in the field of immunoturbidimetric assays.
On the basis of applications, the market is divided into cardiovascular disease, cancer, diabetes, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others. The cardiovascular disease segment has a considerable market share and this trend is expected to continue during the forecast period. Factors such as rising incidence of cardiovascular diseases, rapid growth of the elderly population, and increasing use of CRP testing to determine the risk of heart attack or stroke are anticipated to play an important role in the field of cardiovascular diseases.
In terms of end-uses, the market is segregated into clinics, hospitals, diagnostic labs, and others. The clinics segment has a considerable market share and this trend is expected to continue during the forecast period. Testing in primary health care institutions, availability of testing, and increasing need to improve the diagnosis and treatment of chronic inflammatory diseases in primary and secondary health care institutions are expected to play an important role in the clinics segment.
Based on regions, the market is divided into North America, Asia Pacific, Latin America, Middle East and Africa, and Europe. Asia Pacific has a significant market share and this trend is expected to continue during the forecast period. The market in Asia Pacific is majorly driven by the development of advanced CRP testing, development of modern medical facilities, and lifestyle changes, which led to an increase in the prevalence of cardiovascular diseases.
Segments
Segments Covered in the ReportThe global C-reactive protein testing market has been segmented on the basis of:
Assay Types
- Immunoturbidimetric
- ELISA
- Turbidometric
- Others
- Cardiovascular disease
- Cancer
- Diabetes
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Clinics
- Hospitals
- Diagnostic Labs
- Others
- North America
- Asia-Pacific
- Middle East and Africa
- Latin America
- Europe
- Hoffmann-La Roche Ltd.
- Danaher
- Quest Diagnostics Incorporated
- Siemens
- Abbott Laboratories
- Laboratory Corporation of America Holdings
- Merck KGaA
- Abaxis Inc.
- Ortho Clinical Diagnostics
- Getein Biotech Inc.
- HORIBA Ltd.
- Randox Laboratories Ltd.
- BODITECH MED INC.
- Aidianm
Competitive Landscape
In the competitive environment, companies are adopting different strategies to capture the market and offer tough competition to their competitors. Companies focus on R&D, product launches, product approvals, patents, merger & acquisitions, partnerships, and collaborations. These strategies help in capturing large market share in the long-run. Some of the key players in the market are: Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics Incorporated, Siemens, Abbott Laboratories, Laboratory Corporation of America Holdings, Merck KGaA, Abaxis, Inc., Ortho Clinical Diagnostics, Getein Biotech, Inc., HORIBA, Ltd., Randox Laboratories Ltd., BODITECH MED INC., and Aidianm.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. C-Reactive Protein Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. C-Reactive Protein Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. C-Reactive Protein Testing Market - Supply Chain
4.5. Global C-Reactive Protein Testing Market Forecast
4.5.1. C-Reactive Protein Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. C-Reactive Protein Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. C-Reactive Protein Testing Market Absolute $ Opportunity
5. Global C-Reactive Protein Testing Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. C-Reactive Protein Testing Market Size and Volume Forecast by Types
5.3.1. Immunoturbidimetric
5.3.2. ELISA
5.3.3. Turbidometric
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global C-Reactive Protein Testing Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. C-Reactive Protein Testing Market Size and Volume Forecast by Applications
6.3.1. Cardiovascular disease
6.3.2. Cancer
6.3.3. Diabetes
6.3.4. Rheumatoid Arthritis
6.3.5. Inflammatory Bowel Disease
6.3.6. Endometriosis
6.3.7. Lupus
6.3.8. Other
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global C-Reactive Protein Testing Market Analysis and Forecast by End Users
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by End Users
7.2.2. Y-o-Y Growth Projections by End Users
7.3. C-Reactive Protein Testing Market Size and Volume Forecast by End Users
7.3.1. Clinics
7.3.2. Hospitals
7.3.3. Diagnostic Labs
7.3.4. Others
7.4. Absolute $ Opportunity Assessment by End Users
7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global C-Reactive Protein Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. C-Reactive Protein Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global C-Reactive Protein Testing Demand Share Forecast, 2019-2026
9. North America C-Reactive Protein Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America C-Reactive Protein Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America C-Reactive Protein Testing Market Size and Volume Forecast by Types
9.4.1. Immunoturbidimetric
9.4.2. ELISA
9.4.3. Turbidometric
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. North America C-Reactive Protein Testing Market Size and Volume Forecast by Applications
9.7.1. Cardiovascular disease
9.7.2. Cancer
9.7.3. Diabetes
9.7.4. Rheumatoid Arthritis
9.7.5. Inflammatory Bowel Disease
9.7.6. Endometriosis
9.7.7. Lupus
9.7.8. Other
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. North America C-Reactive Protein Testing Market Size and Volume Forecast by End Users
9.10.1. Clinics
9.10.2. Hospitals
9.10.3. Diagnostic Labs
9.10.4. Others
9.11. Basis Point Share (BPS) Analysis by End Users
9.12. Y-o-Y Growth Projections by End Users
9.13. Market Attractiveness/Growth Potential Analysis
9.13.1. By Country
9.13.2. By Product Type
9.13.3. By Application
9.14. North America C-Reactive Protein Testing Demand Share Forecast, 2019-2026
10. Latin America C-Reactive Protein Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Types
10.4.1. Immunoturbidimetric
10.4.2. ELISA
10.4.3. Turbidometric
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Applications
10.7.1. Cardiovascular disease
10.7.2. Cancer
10.7.3. Diabetes
10.7.4. Rheumatoid Arthritis
10.7.5. Inflammatory Bowel Disease
10.7.6. Endometriosis
10.7.7. Lupus
10.7.8. Other
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by End Users
10.10.1. Clinics
10.10.2. Hospitals
10.10.3. Diagnostic Labs
10.10.4. Others
10.11. Basis Point Share (BPS) Analysis by End Users
10.12. Y-o-Y Growth Projections by End Users
10.13. Market Attractiveness/Growth Potential Analysis
10.13.1. By Country
10.13.2. By Product Type
10.13.3. By Application
10.14. Latin America C-Reactive Protein Testing Demand Share Forecast, 2019-2026
11. Europe C-Reactive Protein Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Types
11.4.1. Immunoturbidimetric
11.4.2. ELISA
11.4.3. Turbidometric
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Applications
11.7.1. Cardiovascular disease
11.7.2. Cancer
11.7.3. Diabetes
11.7.4. Rheumatoid Arthritis
11.7.5. Inflammatory Bowel Disease
11.7.6. Endometriosis
11.7.7. Lupus
11.7.8. Other
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Europe C-Reactive Protein Testing Market Size and Volume Forecast by End Users
11.10.1. Clinics
11.10.2. Hospitals
11.10.3. Diagnostic Labs
11.10.4. Others
11.11. Basis Point Share (BPS) Analysis by End Users
11.12. Y-o-Y Growth Projections by End Users
11.13. Market Attractiveness/Growth Potential Analysis
11.13.1. By Country
11.13.2. By Product Type
11.13.3. By Application
11.14. Europe C-Reactive Protein Testing Demand Share Forecast, 2019-2026
12. Asia Pacific C-Reactive Protein Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Types
12.4.1. Immunoturbidimetric
12.4.2. ELISA
12.4.3. Turbidometric
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Applications
12.7.1. Cardiovascular disease
12.7.2. Cancer
12.7.3. Diabetes
12.7.4. Rheumatoid Arthritis
12.7.5. Inflammatory Bowel Disease
12.7.6. Endometriosis
12.7.7. Lupus
12.7.8. Other
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by End Users
12.10.1. Clinics
12.10.2. Hospitals
12.10.3. Diagnostic Labs
12.10.4. Others
12.11. Basis Point Share (BPS) Analysis by End Users
12.12. Y-o-Y Growth Projections by End Users
12.13. Market Attractiveness/Growth Potential Analysis
12.13.1. By Country
12.13.2. By Product Type
12.13.3. By Application
12.14. Asia Pacific C-Reactive Protein Testing Demand Share Forecast, 2019-2026
13. Middle East & Africa C-Reactive Protein Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Middle East & Africa Average Pricing Analysis
13.2. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Types
13.4.1. Immunoturbidimetric
13.4.2. ELISA
13.4.3. Turbidometric
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Types
13.6. Y-o-Y Growth Projections by Types
13.7. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Applications
13.7.1. Cardiovascular disease
13.7.2. Cancer
13.7.3. Diabetes
13.7.4. Rheumatoid Arthritis
13.7.5. Inflammatory Bowel Disease
13.7.6. Endometriosis
13.7.7. Lupus
13.7.8. Other
13.8. Basis Point Share (BPS) Analysis by Applications
13.9. Y-o-Y Growth Projections by Applications
13.10. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by End Users
13.10.1. Clinics
13.10.2. Hospitals
13.10.3. Diagnostic Labs
13.10.4. Others
13.11. Basis Point Share (BPS) Analysis by End Users
13.12. Y-o-Y Growth Projections by End Users
13.13. Market Attractiveness/Growth Potential Analysis
13.13.1. By Country
13.13.2. By Product Type
13.13.3. By Application
13.14. Middle East & Africa C-Reactive Protein Testing Demand Share Forecast, 2019-2026
14. Competition Landscape
14.1. Global C-Reactive Protein Testing Market: Market Share Analysis
14.2. C-Reactive Protein Testing Distributors and Customers
14.3. C-Reactive Protein Testing Market: Competitive Dashboard
14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
14.4.1. Hoffmann-La Roche Ltd.
14.4.2. Danaher
14.4.3. Quest Diagnostics Incorporated
14.4.4. Siemens
14.4.5. Abbott Laboratories
14.4.6. Laboratory Corporation of America Holdings
14.4.7. Merck KGaA
14.4.8. Abaxis Inc.&l
2. Assumptions and Acronyms Used
3. Research Methodology
4. C-Reactive Protein Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. C-Reactive Protein Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. C-Reactive Protein Testing Market - Supply Chain
4.5. Global C-Reactive Protein Testing Market Forecast
4.5.1. C-Reactive Protein Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. C-Reactive Protein Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. C-Reactive Protein Testing Market Absolute $ Opportunity
5. Global C-Reactive Protein Testing Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. C-Reactive Protein Testing Market Size and Volume Forecast by Types
5.3.1. Immunoturbidimetric
5.3.2. ELISA
5.3.3. Turbidometric
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global C-Reactive Protein Testing Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. C-Reactive Protein Testing Market Size and Volume Forecast by Applications
6.3.1. Cardiovascular disease
6.3.2. Cancer
6.3.3. Diabetes
6.3.4. Rheumatoid Arthritis
6.3.5. Inflammatory Bowel Disease
6.3.6. Endometriosis
6.3.7. Lupus
6.3.8. Other
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global C-Reactive Protein Testing Market Analysis and Forecast by End Users
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by End Users
7.2.2. Y-o-Y Growth Projections by End Users
7.3. C-Reactive Protein Testing Market Size and Volume Forecast by End Users
7.3.1. Clinics
7.3.2. Hospitals
7.3.3. Diagnostic Labs
7.3.4. Others
7.4. Absolute $ Opportunity Assessment by End Users
7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global C-Reactive Protein Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. C-Reactive Protein Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global C-Reactive Protein Testing Demand Share Forecast, 2019-2026
9. North America C-Reactive Protein Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America C-Reactive Protein Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America C-Reactive Protein Testing Market Size and Volume Forecast by Types
9.4.1. Immunoturbidimetric
9.4.2. ELISA
9.4.3. Turbidometric
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. North America C-Reactive Protein Testing Market Size and Volume Forecast by Applications
9.7.1. Cardiovascular disease
9.7.2. Cancer
9.7.3. Diabetes
9.7.4. Rheumatoid Arthritis
9.7.5. Inflammatory Bowel Disease
9.7.6. Endometriosis
9.7.7. Lupus
9.7.8. Other
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. North America C-Reactive Protein Testing Market Size and Volume Forecast by End Users
9.10.1. Clinics
9.10.2. Hospitals
9.10.3. Diagnostic Labs
9.10.4. Others
9.11. Basis Point Share (BPS) Analysis by End Users
9.12. Y-o-Y Growth Projections by End Users
9.13. Market Attractiveness/Growth Potential Analysis
9.13.1. By Country
9.13.2. By Product Type
9.13.3. By Application
9.14. North America C-Reactive Protein Testing Demand Share Forecast, 2019-2026
10. Latin America C-Reactive Protein Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Types
10.4.1. Immunoturbidimetric
10.4.2. ELISA
10.4.3. Turbidometric
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by Applications
10.7.1. Cardiovascular disease
10.7.2. Cancer
10.7.3. Diabetes
10.7.4. Rheumatoid Arthritis
10.7.5. Inflammatory Bowel Disease
10.7.6. Endometriosis
10.7.7. Lupus
10.7.8. Other
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Latin America C-Reactive Protein Testing Market Size and Volume Forecast by End Users
10.10.1. Clinics
10.10.2. Hospitals
10.10.3. Diagnostic Labs
10.10.4. Others
10.11. Basis Point Share (BPS) Analysis by End Users
10.12. Y-o-Y Growth Projections by End Users
10.13. Market Attractiveness/Growth Potential Analysis
10.13.1. By Country
10.13.2. By Product Type
10.13.3. By Application
10.14. Latin America C-Reactive Protein Testing Demand Share Forecast, 2019-2026
11. Europe C-Reactive Protein Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Types
11.4.1. Immunoturbidimetric
11.4.2. ELISA
11.4.3. Turbidometric
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Europe C-Reactive Protein Testing Market Size and Volume Forecast by Applications
11.7.1. Cardiovascular disease
11.7.2. Cancer
11.7.3. Diabetes
11.7.4. Rheumatoid Arthritis
11.7.5. Inflammatory Bowel Disease
11.7.6. Endometriosis
11.7.7. Lupus
11.7.8. Other
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Europe C-Reactive Protein Testing Market Size and Volume Forecast by End Users
11.10.1. Clinics
11.10.2. Hospitals
11.10.3. Diagnostic Labs
11.10.4. Others
11.11. Basis Point Share (BPS) Analysis by End Users
11.12. Y-o-Y Growth Projections by End Users
11.13. Market Attractiveness/Growth Potential Analysis
11.13.1. By Country
11.13.2. By Product Type
11.13.3. By Application
11.14. Europe C-Reactive Protein Testing Demand Share Forecast, 2019-2026
12. Asia Pacific C-Reactive Protein Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Types
12.4.1. Immunoturbidimetric
12.4.2. ELISA
12.4.3. Turbidometric
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by Applications
12.7.1. Cardiovascular disease
12.7.2. Cancer
12.7.3. Diabetes
12.7.4. Rheumatoid Arthritis
12.7.5. Inflammatory Bowel Disease
12.7.6. Endometriosis
12.7.7. Lupus
12.7.8. Other
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Asia Pacific C-Reactive Protein Testing Market Size and Volume Forecast by End Users
12.10.1. Clinics
12.10.2. Hospitals
12.10.3. Diagnostic Labs
12.10.4. Others
12.11. Basis Point Share (BPS) Analysis by End Users
12.12. Y-o-Y Growth Projections by End Users
12.13. Market Attractiveness/Growth Potential Analysis
12.13.1. By Country
12.13.2. By Product Type
12.13.3. By Application
12.14. Asia Pacific C-Reactive Protein Testing Demand Share Forecast, 2019-2026
13. Middle East & Africa C-Reactive Protein Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Middle East & Africa Average Pricing Analysis
13.2. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Types
13.4.1. Immunoturbidimetric
13.4.2. ELISA
13.4.3. Turbidometric
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Types
13.6. Y-o-Y Growth Projections by Types
13.7. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by Applications
13.7.1. Cardiovascular disease
13.7.2. Cancer
13.7.3. Diabetes
13.7.4. Rheumatoid Arthritis
13.7.5. Inflammatory Bowel Disease
13.7.6. Endometriosis
13.7.7. Lupus
13.7.8. Other
13.8. Basis Point Share (BPS) Analysis by Applications
13.9. Y-o-Y Growth Projections by Applications
13.10. Middle East & Africa C-Reactive Protein Testing Market Size and Volume Forecast by End Users
13.10.1. Clinics
13.10.2. Hospitals
13.10.3. Diagnostic Labs
13.10.4. Others
13.11. Basis Point Share (BPS) Analysis by End Users
13.12. Y-o-Y Growth Projections by End Users
13.13. Market Attractiveness/Growth Potential Analysis
13.13.1. By Country
13.13.2. By Product Type
13.13.3. By Application
13.14. Middle East & Africa C-Reactive Protein Testing Demand Share Forecast, 2019-2026
14. Competition Landscape
14.1. Global C-Reactive Protein Testing Market: Market Share Analysis
14.2. C-Reactive Protein Testing Distributors and Customers
14.3. C-Reactive Protein Testing Market: Competitive Dashboard
14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
14.4.1. Hoffmann-La Roche Ltd.
14.4.2. Danaher
14.4.3. Quest Diagnostics Incorporated
14.4.4. Siemens
14.4.5. Abbott Laboratories
14.4.6. Laboratory Corporation of America Holdings
14.4.7. Merck KGaA
14.4.8. Abaxis Inc.&l
Segments Covered in the Report
The global C-reactive protein testing market has been segmented on the basis of:
Assay Types
The global C-reactive protein testing market has been segmented on the basis of:
Assay Types
- Immunoturbidimetric
- ELISA
- Turbidometric
- Others
- Cardiovascular disease
- Cancer
- Diabetes
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Clinics
- Hospitals
- Diagnostic Labs
- Others
- North America
- Asia-Pacific
- Middle East and Africa
- Latin America
- Europe
- Hoffmann-La Roche Ltd.
- Danaher
- Quest Diagnostics Incorporated
- Siemens
- Abbott Laboratories
- Laboratory Corporation of America Holdings
- Merck KGaA
- Abaxis Inc.
- Ortho Clinical Diagnostics
- Getein Biotech Inc.
- HORIBA Ltd.
- Randox Laboratories Ltd.
- BODITECH MED INC.
- Aidianm
In the competitive environment, companies are adopting different strategies to capture the market and offer tough competition to their competitors. Companies focus on R&D, product launches, product approvals, patents, merger & acquisitions, partnerships, and collaborations. These strategies help in capturing large market share in the long-run. Some of the key players in the market are: Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics Incorporated, Siemens, Abbott Laboratories, Laboratory Corporation of America Holdings, Merck KGaA, Abaxis, Inc., Ortho Clinical Diagnostics, Getein Biotech, Inc., HORIBA, Ltd., Randox Laboratories Ltd., BODITECH MED INC., and Aidianm.
Our Clients
Related Reports
Some other reports from this category!
